BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3058118)

  • 21. Characterization of proteases and protease inhibitors in the rat stomach.
    Nagy L; Johnson BR; Hauschka P; Szabo S
    Am J Physiol; 1997 May; 272(5 Pt 1):G1151-8. PubMed ID: 9176225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.
    Delaissé JM; Ledent P; Vaes G
    Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):167-74. PubMed ID: 1930136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunocytochemical study on distinct intracellular localization of cathepsin E and cathepsin D in human gastric cells and various rat cells.
    Saku T; Sakai H; Shibata Y; Kato Y; Yamamoto K
    J Biochem; 1991 Dec; 110(6):956-64. PubMed ID: 1794985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and characterization of acid proteinase from human erythrocyte membranes.
    Yamamoto K; Marchesi VT
    Biochim Biophys Acta; 1984 Nov; 790(3):208-18. PubMed ID: 6386053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of brain cathepsin B, cathepsin D, and high-molecular-weight aspartic proteinase on angiotensins I and II.
    Azaryan A; Barkhudaryan N; Galoyan A; Lajtha A
    Neurochem Res; 1985 Nov; 10(11):1525-32. PubMed ID: 3911093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Proteinases of small intestine enterocytes of swine. Purification and properties of aspartyl proteinase similar to cathepsin D].
    Zil'berman MI; Vorotyntseva TI
    Biokhimiia; 1985 Sep; 50(9):1453-62. PubMed ID: 3931702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrolysis of histones by proteinases.
    Harvima RJ; Yabe K; Fräki JE; Fukuyama K; Epstein WL
    Biochem J; 1988 Mar; 250(3):859-64. PubMed ID: 2968788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the specificity of the aspartic proteinases towards internally consistent sets of oligopeptide substrates.
    Dunn BM; Oda K; Kay J; Rao-Naik C; Lowther WT; Beyer BM; Scarborough PE; Bukhtiyarova M
    Adv Exp Med Biol; 1998; 436():133-8. PubMed ID: 9561210
    [No Abstract]   [Full Text] [Related]  

  • 29. Isolation, and catalytic and immunochemical properties of cathepsin D-like acid proteinase from rat erythrocytes.
    Takeda M; Ueno E; Kato Y; Yamamoto K
    J Biochem; 1986 Nov; 100(5):1269-77. PubMed ID: 3546279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
    Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
    Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new chromophoric substrate for penicillopepsin and other fungal aspartic proteinases.
    Hofmann T; Hodges RS
    Biochem J; 1982 Jun; 203(3):603-10. PubMed ID: 7052062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunolocalisation of aspartic proteinases in the developing human stomach.
    Reid WA; McGechaen K; Branch T; Gray HD; Thompson WD; Kay J
    J Dev Physiol; 1989 May; 11(5):299-303. PubMed ID: 2693525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and immunohistochemical localization of aspartic proteinases in rat epidermis.
    Hara K; Fukuyama K; Sakai H; Yamamoto K; Epstein WL
    J Invest Dermatol; 1993 Apr; 100(4):394-9. PubMed ID: 8454902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [p-Nitroanilides of amino acids and peptides and fluorescence peptide with inner fluorescence quenching as substrates for cathepsins H, B, D and high molecular weight aspartic peptidase in the brain].
    Azarian AV; Agatian GL; Galoian AA
    Biokhimiia; 1987 Dec; 52(12):2033-7. PubMed ID: 3328984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and some properties of a cathepsin E type proteinase from rat spleen.
    Wiederanders B; Schaper S; Kirschke H
    Biomed Biochim Acta; 1989; 48(1):23-32. PubMed ID: 2775249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.
    Richards AD; Roberts R; Dunn BM; Graves MC; Kay J
    FEBS Lett; 1989 Apr; 247(1):113-7. PubMed ID: 2651157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The selectivity of statine-based inhibitors against various human aspartic proteinases.
    Jupp RA; Dunn BM; Jacobs JW; Vlasuk G; Arcuri KE; Veber DF; Perlow DS; Payne LS; Boger J; de Laszlo S
    Biochem J; 1990 Feb; 265(3):871-8. PubMed ID: 2407237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling.
    Scarborough PE; Guruprasad K; Topham C; Richo GR; Conner GE; Blundell TL; Dunn BM
    Protein Sci; 1993 Feb; 2(2):264-76. PubMed ID: 8443603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation mechanism of erythrocyte cathepsin E. evidence for the occurrence of the membrane-associated active enzyme.
    Ueno E; Sakai H; Kato Y; Yamamoto K
    J Biochem; 1989 Jun; 105(6):878-82. PubMed ID: 2670917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.